BT CEO snaps up 400,000 sharesGSK CEO offloads £2.3 million sharesPoolbeg Pharma chairman ups his stakeAllison Kirkby CEO of BT (BT.A) has bought 400,000 shares at 107p for a total value of £428,000 on 20 February.The move comes as the telecoms giant announced that it was offloading its iconic ?BT Tower? in London?s Fitzrovia to MCR for £275 million.The company announced Kirkby?s...

THIS IS AN ADVERTISING PROMOTIONInfectious diseases have, over the last decade, been a relatively under-funded area of pharmaceutical research with 'Big Pharma' deprioritising R&D in this space.But then an unprecedented global pandemic brought about devastating human and economic damage, the impact of which will take a generation to overcome. For the pharmaceutical and biotech sectors, it has...